DOJ cites $330 trillion in Camp Lejeune claims during the Fancher trial, drawing criticism from advocates Mike Partain and Jerry Ensminger as federal scientist Frank Bove challenges the government's interpretation of kidney cancer research.
Local Features
Latest from NPR
-
A federal judge in Charlotte heard arguments Wednesday over whether U.S. Immigration and Customs Enforcement must publish its full memo expanding electronic monitoring of immigrants.
-
Bennett College students and alumni are asking leaders to not sell a painting of Harriet Tubman belonging to the school that’s estimated to be worth millions.
-
It's been a year since the House passed the Epstein Files Transparency Act, forcing the Justice Department to release millions of files connected to the convicted sex offender. His victims speak out.
-
The Nvidia scandal has spilled over into the Trump administration, which is now under intense scrutiny for how it allowed America's top AI chips to end up in China's hands.
-
NPR's Scott Detrow speaks with Lindsay Ellis from The Wall Street Journal about why it's so hard for white collar workers to find jobs right now.
-
NPR's Juana Summers speaks with K Chiucarello about their debut novel — Nanny Nanny. The main character is wrestling with past abuse and her desire to be a parent.
-
In communities struck by Hurricane Helene, researchers have a rare chance to see how big storms increase the amount of microplastics in the environment.
-
Democrats gave the official nod to Hakeem Jeffries to be the next speaker of the House. Meanwhile, Democrats are ramping up their plans to investigate the Trump administration come January.
-
As the emergency response to the flood ends, aid workers turn to the hard work of rebuilding communities that lost everything. Many of those workers lost everything, too.
-
On the eve of a key Senate vote, the White House withdrew Dr. Heidi Overton's nomination to run the Food and Drug Administration.
Fall 2026 Resiliency Strategy Series
Major Partner
Event Sponsors